StocksMedium•5 November 2026•
1 min read
Vera Therapeutics Reports Narrower-Than-Expected Q3 2026 Loss
Key Facts
1Vera Therapeutics reported a quarterly loss of $1.3 per share, narrower than the Zacks Consensus Estimate of a $1.72 loss.
2The current quarter's results compare to a loss of $1.26 per share reported a year ago.
Vera Therapeutics reported a quarterly loss of $1.3 per share for the third quarter of 2026. Zacks reported that these results were narrower than the consensus estimate of a $1.72 loss, representing a beat on bottom-line expectations.
The current results compare to a loss of $1.26 per share reported in the same period last year, indicating a year-over-year increase in net loss. VERA closed at $31.97 on November 4, 2026.